key: cord-293378-bi3lcj09
authors: Teven, Chad M.; Song, David H.
title: Patient Counseling in Plastic Surgery during Coronavirus Disease 2019
date: 2020-05-13
journal: Plast Reconstr Surg Glob Open
DOI: 10.1097/gox.0000000000002924
sha: 
doc_id: 293378
cord_uid: bi3lcj09

nan

an ongoing public health crisis. As of April 19, 749,666 cases and 35,012 deaths have been confirmed in the United States. 1 In response, hospitals have implemented significant changes to normal operating procedures to address anticipated needs of infected patients. One key example is cancellation of nontime-sensitive elective surgery. Because the majority of plastic surgical procedures fall under this classification, the current pandemic has profound effects on plastic surgery.

Due to effective social distancing, recent models report reduced COVID-19-related death estimates and flattening of the curve. 2 In response, hospitals have started preparing for a return to normal operations. Several institutions, including ours, recently relaxed restrictions on surgery, permitting some elective procedures to proceed. It is, therefore, critical that both surgeons and patients understand additional risks present in the setting of the COVID-19 pandemic.

A recent report by Bryan et al 3 highlighted several considerations for surgical patients during the pandemic (Table 1) . First, there is a lack of evidence demonstrating how infected patients tolerate routine procedures, including physiologic response to surgery and anesthesia. Second, patients have an unknown but presumably heightened risk of nosocomial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Third, changes in normal perioperative procedures, such as visitor restrictions or limited nursing staff, may impact care. Finally, resource shortages may alter postoperative care, both in cases of successful surgery and when complications arise. 3 We agree on the importance of informing patients of these issues. However, there are risks specific to plastic surgery that must also be addressed (Table 1) .

First, there appears to be an increased risk of thromboembolic complications in COVID-19-positive patients. 4 Whether this translates to an increased risk of thrombosis in microvascular surgery or for procedures with a high relative risk of thromboembolism (eg, abdominoplasty) remains uncertain. Second, many procedures are staged, such as prosthetic breast reconstruction and forehead flaps. Due to unforeseen issues related to the pandemic, patients may experience atypically long delays to the second procedure. Similarly, revision surgery may be delayed indefinitely if hospital resources become limited. Third, although changes to the riskbenefit calculus for common procedures are expected, the degree of change remains unknown. For example, evidence regarding the safety of delaying versus performing nonelective, nonemergent surgery (eg, skin cancer resection) in patients at risk for severe COVID-19 infection (eg, elderly and/or comorbidities) is limited. Additional risks will certainly arise in specific cases and must be addressed accordingly.

Moving forward, we offer recommendations to facilitate appropriate care during the pandemic (Table 2) . First, during the informed consent process, in addition to case-specific risks, benefits, and alternatives, implications of surgery during the pandemic must be discussed and documented accordingly. Next, whenever 3 the use of advanced directives and living wills is encouraged, given the high degree of uncertainty surrounding surgery and COVID-19. 3 Finally, application of sound clinical judgment, shared decision-making, and a patient-centered approach will facilitate improved care, particularly where clinical evidence is lacking. 5

Mayo Clinic 5779 E. Mayo Blvd. Phoenix, AZ 85054 E-mail: teven.chad@mayo.edu

Johns Hopkins Coronavirus Resource Center

Available at covid19.healthdata.org/united-states-of-america

Unknown unknowns: surgical consent during the COVID-19 pandemic

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Shared decision making: a model for clinical practice

The authors have no financial interest to declare in relation to the content of this article.